Press Release: Merit Completes COVID-19 Vaccine Testing Laboratories for SGS

UK offsite construction specialist, Merit, has completed construction of two new laboratories for SGS at its Biosafety Centre of Excellence in Glasgow.

The new laboratories are a further expansion of SGS’ capacity for quality control and analytical testing services in support of COVID 19 vaccine candidates at the Glasgow facility.

Merit converted existing building space into two separate GMP and BSL-2 laboratories with common changing facilities and dedicated air handling units and extract systems with safe change HEPA filtering.

Last year, Merit completed a complex expansion project to transform an existing two-storey building into laboratories at the Glasgow SGS Biosafety Centre.

Tony Wells, Managing Director at Merit, said:
“Our team has worked closely with SGS to ensure that the technical specifications are fully met and the new laboratories have been delivered to the highest quality.

“SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognised as the global benchmark for quality and integrity and requires the most stringent standards of technical precision and hygiene in its laboratories. We are proud to have delivered another first-class facility for them.”

Merit is one of the UK’s leading offsite engineering and construction specialists and prides itself on the ability to design and engineer controlled environment solutions for the bioscience, pharmaceutical, semiconductor, aviation and nuclear sectors, specialising in the delivery of complex cleanroom construction and M&E services that require stringent regulatory approvals.

About SGS

SGS leverages its digitalized network of life science laboratories, present in North America, Europe and Asia-Pacific, to deliver harmonised testing solutions for analytical development, biologics characterisation, biosafety and quality control, as well as clinical trial management to large pharmaceutical and biotechnology firms.